Royal Bank Of Canada Phathom Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 7,006 shares of PHAT stock, worth $62,843. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,006

Previous 4,253 64.73%

Holding current value

$62,843

Previous $43,000 193.02%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.25 - $19.5 $28,218 - $53,683	2,753 Added 64.73%	7,006 $126,000
Q2 2024 Aug 14, 2024	BUY	$8.97 - $12.05 $20,065 - $26,955	2,237 Added 110.96%	4,253 $43,000
Q1 2024 Nov 05, 2024	SELL	$6.21 - $11.05 $13,891 - $24,718	-2,237 Reduced 52.6%	2,016 $21,000
Q1 2024 May 15, 2024	SELL	$6.21 - $11.05 $52,263 - $92,996	-8,416 Reduced 80.67%	2,016 $21,000
Q4 2023 Feb 14, 2024	BUY	$6.99 - $10.71 $32,964 - $50,508	4,716 Added 82.51%	10,432 $95,000
Q3 2023 Nov 14, 2023	BUY	$10.26 - $15.7 $32,975 - $50,459	3,214 Added 128.46%	5,716 $59,000
Q2 2023 Aug 14, 2023	BUY	$7.28 - $14.32 $4,491 - $8,835	617 Added 32.73%	2,502 $35,000
Q1 2023 May 15, 2023	SELL	$6.19 - $12.36 $13,952 - $27,859	-2,254 Reduced 54.46%	1,885 $13,000
Q4 2022 Feb 14, 2023	BUY	$9.18 - $11.53 $35,425 - $44,494	3,859 Added 1378.21%	4,139 $46,000
Q3 2022 Nov 14, 2022	BUY	$6.46 - $12.11 $969 - $1,816	150 Added 115.38%	280 $3,000
Q2 2022 Aug 15, 2022	SELL	$6.2 - $15.5 $6,906 - $17,267	-1,114 Reduced 89.55%	130 $1,000
Q1 2022 May 16, 2022	SELL	$11.55 - $20.06 $36,994 - $64,252	-3,203 Reduced 72.03%	1,244 $17,000
Q4 2021 Feb 14, 2022	BUY	$17.83 - $33.15 $45,983 - $85,493	2,579 Added 138.06%	4,447 $87,000
Q3 2021 Nov 15, 2021	BUY	$30.69 - $36.83 $14,761 - $17,715	481 Added 34.68%	1,868 $60,000
Q2 2021 Aug 16, 2021	BUY	$32.66 - $39.87 $45,299 - $55,299	1,387 New	1,387 $47,000

Others Institutions Holding PHAT

# of Institutions

144

Shares Held

73.6M

Call Options Held

42.3K

Put Options Held

45.7K

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $351M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Phathom Pharmaceuticals, Inc. Transaction History